AR053827A1 - Composiciones de tigeciclina y metodos de preparacion - Google Patents

Composiciones de tigeciclina y metodos de preparacion

Info

Publication number
AR053827A1
AR053827A1 ARP060100950A ARP060100950A AR053827A1 AR 053827 A1 AR053827 A1 AR 053827A1 AR P060100950 A ARP060100950 A AR P060100950A AR P060100950 A ARP060100950 A AR P060100950A AR 053827 A1 AR053827 A1 AR 053827A1
Authority
AR
Argentina
Prior art keywords
compositions
tigecicline
preparation methods
tigecycline
elaboration
Prior art date
Application number
ARP060100950A
Other languages
English (en)
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36648809&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR053827(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of AR053827A1 publication Critical patent/AR053827A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente se relaciona con composiciones de tigeciclina con mejor estabilidad, tanto en estados solidos como en solucion, y con procesos para su elaboracion. Estas composiciones comprenden tigeciclina, un carbohidrato adecuado y un ácido o regulador.
ARP060100950A 2005-03-14 2006-03-13 Composiciones de tigeciclina y metodos de preparacion AR053827A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US66103005P 2005-03-14 2005-03-14

Publications (1)

Publication Number Publication Date
AR053827A1 true AR053827A1 (es) 2007-05-23

Family

ID=36648809

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP060100950A AR053827A1 (es) 2005-03-14 2006-03-13 Composiciones de tigeciclina y metodos de preparacion
ARP170102234A AR109500A2 (es) 2005-03-14 2017-08-09 Composiciones de tigeciclina y métodos de preparación

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP170102234A AR109500A2 (es) 2005-03-14 2017-08-09 Composiciones de tigeciclina y métodos de preparación

Country Status (25)

Country Link
US (5) US7879828B2 (es)
EP (1) EP1858488B2 (es)
JP (1) JP4972081B2 (es)
KR (2) KR20130122988A (es)
CN (2) CN101132775A (es)
AR (2) AR053827A1 (es)
AU (1) AU2006223226B2 (es)
BR (1) BRPI0608464A2 (es)
CA (1) CA2602089C (es)
CR (1) CR9416A (es)
CY (1) CY1114504T1 (es)
DK (1) DK1858488T4 (es)
ES (1) ES2434944T5 (es)
GT (1) GT200600112A (es)
HN (1) HN2006011218A (es)
IL (1) IL185924A (es)
MX (1) MX2007010983A (es)
NO (1) NO20074278L (es)
PE (1) PE20061107A1 (es)
PL (1) PL1858488T5 (es)
PT (1) PT1858488E (es)
RU (1) RU2428190C2 (es)
TW (1) TW200700092A (es)
WO (1) WO2006099258A1 (es)
ZA (1) ZA200707831B (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007010983A (es) 2005-03-14 2007-09-19 Wyeth Corp Composiciones de tigeciclina y metodos de preparacion.
AR057649A1 (es) * 2005-05-27 2007-12-12 Wyeth Corp Formas solidas cristalinas de tigeciclina y metodos para preparar las mismas
PE20070072A1 (es) * 2005-06-16 2007-02-25 Wyeth Corp Proceso de manufactura para tigeciclina como polvo reconstituible
US7645789B2 (en) 2006-04-07 2010-01-12 Vertex Pharmaceuticals Incorporated Indole derivatives as CFTR modulators
WO2007120913A2 (en) * 2006-04-17 2007-10-25 Teva Pharmaceutical Industries Ltd. Isolation of tetracycline derivatives
EP2426104A1 (en) * 2006-04-24 2012-03-07 Teva Pharmaceutical Industries Ltd. Tigecycline crystalline form and process for preparation thereof
US8198470B2 (en) * 2006-04-24 2012-06-12 Teva Pharmaceutical Industries Ltd. Crystalline form II of tigecycline and processes for preparation thereof
FR2910812B1 (fr) 2006-12-29 2009-03-20 Pierre Fabre Medicament Sa Compositions pharmaceutiques injectables lyophilisees de derives hemi-synthetiques d'alcaloide de vinca stables a temperature ambiante
PT2271348T (pt) * 2008-03-28 2018-04-16 Paratek Pharm Innc Formulação de comprimido oral de composto de tetraciclina
US9107929B2 (en) 2008-05-01 2015-08-18 Ranbaxy Laboratories Limited Stable parenteral formulations of tigecycline
US20100035845A1 (en) * 2008-08-06 2010-02-11 Wyeth Tigecycline formulations
CN102138925B (zh) * 2010-01-29 2014-06-25 正大天晴药业集团股份有限公司 替加环素组合物及其制备方法
PL2568987T3 (pl) * 2010-05-12 2017-06-30 Rempex Pharmaceuticals, Inc. Kompozycje tetracyklinowe
WO2012169435A1 (ja) 2011-06-07 2012-12-13 旭化成ファーマ株式会社 高純度ｐｔｈ含有凍結乾燥製剤およびその製造方法
CN102391148B (zh) * 2011-10-24 2014-01-08 江苏奥赛康药业股份有限公司 一种高纯度替加环素的合成方法
CN103315947B (zh) 2012-03-22 2016-01-20 上海汇伦生命科技有限公司 一种注射用替加环素组合物
CN103356662B (zh) * 2012-03-27 2015-11-25 浙江医药股份有限公司新昌制药厂 注射用替加环素组合物及其制备方法
CN102641249A (zh) * 2012-05-06 2012-08-22 江苏奥赛康药业股份有限公司 一种替加环素组合物的制备方法
CN103417498B (zh) * 2012-05-18 2017-09-12 山东新时代药业有限公司 一种替加环素冻干粉针剂的制备方法
CN102697739B (zh) * 2012-05-31 2014-10-29 丽珠医药集团股份有限公司 一种减少替加环素差向异构体化的粉针剂制备方法
CN102911077B (zh) * 2012-11-12 2015-01-07 成都百裕科技制药有限公司 4r-替加环素的制备方法
WO2014167575A2 (en) * 2013-03-26 2014-10-16 Astron Research Limited Stable tigecycline composition
IN2013MU01127A (es) 2013-03-26 2015-05-01 Astron Res Ltd
CN104107170A (zh) * 2013-04-22 2014-10-22 上海汇伦生命科技有限公司 一种替加环素组合物
US20140323443A1 (en) * 2013-04-30 2014-10-30 Fresenius Kabi Usa, Llc Tigecycline formulations
US20160143925A1 (en) 2013-11-12 2016-05-26 Galenicum Health S.L. Stable pharmaceutical compositions
NO2723977T3 (es) 2014-03-19 2018-03-10
CN105079816B (zh) * 2015-08-17 2018-09-07 江苏豪森药业集团有限公司 替加环素药物组合物及其制备方法
CN108653216B (zh) * 2018-05-28 2020-12-18 福安药业集团湖北人民制药有限公司 注射用替加环素
WO2021063468A1 (en) 2019-10-02 2021-04-08 Anfarm Hellas S.A. Stable parenteral pharmaceutical composition containing tigecycline and process for the preparation thereof
IT202100031133A1 (it) 2021-12-13 2023-06-13 Zambon Spa Composizione farmaceutica comprendente tigeciclina

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH225704A (de) 1942-01-06 1943-02-15 Schlotterbeck Automobile Aktie Holzgasgenerator.
GB901107A (en) 1959-06-29 1962-07-11 Pfizer Therapeutic composition and method of preparing same
US3026248A (en) 1959-09-11 1962-03-20 Pfizer & Co C Thioglycerol and formaldehyde sulfoxylate stabilized tetracycline antibiotics in polyhydric alcohol solvents
US3106512A (en) * 1961-07-19 1963-10-08 Olin Mathieson Stabilization of tetracycline base in dry form with glucono delta lactone
US3145228A (en) 1962-09-06 1964-08-18 Pfizer & Co C 5-alkoxy-and 5-benzyloxy-tetracycline, derivatives and analogues thereof
US3219529A (en) 1962-10-04 1965-11-23 American Cyanamid Co Stable tetracycline solutions
US4038315A (en) 1972-05-11 1977-07-26 American Cyanamid Company Isolation and recovery of calcium chloride complex of 7-dimethylamino-6-dimethyl l-6-deoxytetracycline hydrochloride
DE2748132A1 (de) 1977-10-27 1979-05-03 Behringwerke Ag Stabilisator fuer polysaccharid
US4457916A (en) 1982-08-31 1984-07-03 Asahi Kasei Kogyo Kabushiki Kaisha Method for stabilizing Tumor Necrosis Factor and a stable aqueous solution or powder containing the same
US4678812A (en) 1986-05-30 1987-07-07 E. I. Du Pont De Nemours And Company Trehalose as stabilizer and tableting excipient
US5122519A (en) * 1989-06-27 1992-06-16 American Cyanamid Company Stable, cosmetically acceptable topical gel formulation and method of treatment for acne
DE69132970T2 (de) 1990-06-22 2002-09-12 Canon Kk Bildverarbeitungsvorrichtung
US5494903A (en) 1991-10-04 1996-02-27 American Cyanamid Company 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
US5538954A (en) 1994-06-24 1996-07-23 A/S Dumex (Dumex Ltd.) Salts of tetracyclines
US5675030A (en) 1994-11-16 1997-10-07 American Cyanamid Company Method for selective extracting a 7-(hydrogen or substituted amino)-9- (substituted glycyl) amido!-6-demethyl-6-deoxytetracycline compound
US6503881B2 (en) * 1996-08-21 2003-01-07 Micrologix Biotech Inc. Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
US5908838A (en) 1998-02-19 1999-06-01 Medics Pharmaceutical Corporation Method for the treatment of acne
ES2281360T3 (es) 1999-09-14 2007-10-01 Mucosal Therapeutics Llc Formulaciones que contienen tetraciclinas para el tratamiento o prevencion de la mucositis.
WO2002012170A1 (en) 2000-08-04 2002-02-14 Trustees Of Tufts College 8-substituted tetracycline compounds
WO2002055731A2 (en) 2001-01-11 2002-07-18 Board Of Regents, The University Of Texas System Dosage adjustement for antibiotics
CA2449002C (en) 2001-05-29 2011-08-16 Tap Pharmaceutical Products Inc. Enhancement of oral bioavailability of non-emulsified formulation of prodrug esters with lecithin
EP2332549A1 (en) 2001-07-13 2011-06-15 Paratek Pharmaceuticals, Inc. Novel tetracyclines and their use in medicine
US20030171340A1 (en) 2002-02-07 2003-09-11 Jenefir Isbister Methods of disease treatment using metal-complexed tetracycline antibiotics
CN1390550A (zh) 2002-07-25 2003-01-15 于航 盐酸米诺环素冻干粉针剂及其制备方法
CA2503446C (en) 2002-10-24 2012-12-18 Paratek Pharmaceuticals, Inc. Methods of using substituted tetracycline compounds to modulate rna
WO2004078111A2 (en) 2003-03-06 2004-09-16 Ranbaxy Laboratories Limited Extended release minocycline compositions and processes for their preparation
CN1568999A (zh) 2003-07-14 2005-01-26 南宁枫叶药业有限公司 稳定的医药用河豚毒素冷冻干燥制剂
US20050148553A1 (en) 2003-09-05 2005-07-07 Testa Raymond T. Use of tigecycline, alone, or in combination with rifampin to treat osteomyelitis and/or septic arthritis
GB2414668B (en) 2004-06-03 2009-07-29 Dexcel Ltd Tetracycline modified release delivery system
BRPI0517406A (pt) 2004-10-28 2008-10-07 Wyeth Corp método de tratamento, controle ou redução do risco de uma infecção bacteriana e um estado de insuficiência cardìaca em um ser humano; método para controle do aumento dos nìveis plasmáticos de digoxina em estado constante em um ser humano; método de tratamento, controle ou redução do risco de uma infecção bacteriana com tigeciclina em um paciente; uso de tigeciclina em combinação com digoxina; e produto compreendendo tigeciclina e digoxina como uma preparação combinada
MX2007010983A (es) * 2005-03-14 2007-09-19 Wyeth Corp Composiciones de tigeciclina y metodos de preparacion.
AR057034A1 (es) 2005-05-27 2007-11-14 Wyeth Corp Metodos para purificar tigeciclina
EP3003273A1 (en) † 2013-05-31 2016-04-13 Xellia Pharmaceuticals ApS A method for stabilizing tigecycline

Also Published As

Publication number Publication date
US9694078B2 (en) 2017-07-04
CA2602089C (en) 2013-04-30
PL1858488T5 (pl) 2024-01-03
US20060247181A1 (en) 2006-11-02
RU2428190C2 (ru) 2011-09-10
WO2006099258A1 (en) 2006-09-21
JP4972081B2 (ja) 2012-07-11
PE20061107A1 (es) 2006-12-08
MX2007010983A (es) 2007-09-19
BRPI0608464A2 (pt) 2010-01-05
KR101354093B1 (ko) 2014-01-24
EP1858488A1 (en) 2007-11-28
CN101132775A (zh) 2008-02-27
TW200700092A (en) 2007-01-01
ES2434944T5 (es) 2022-10-20
AU2006223226B2 (en) 2012-03-15
US9254328B2 (en) 2016-02-09
EP1858488B1 (en) 2013-09-11
JP2008533146A (ja) 2008-08-21
IL185924A (en) 2014-05-28
US20150141379A1 (en) 2015-05-21
NO20074278L (no) 2007-11-20
IL185924A0 (en) 2008-01-06
US20170266290A1 (en) 2017-09-21
HN2006011218A (es) 2008-09-17
US10588975B2 (en) 2020-03-17
US20110118216A1 (en) 2011-05-19
PT1858488E (pt) 2013-11-18
KR20080002828A (ko) 2008-01-04
ZA200707831B (en) 2011-02-23
US7879828B2 (en) 2011-02-01
CA2602089A1 (en) 2006-09-21
CR9416A (es) 2008-03-06
US20160144036A1 (en) 2016-05-26
RU2007131396A (ru) 2009-04-20
DK1858488T4 (da) 2022-09-12
CN102512429A (zh) 2012-06-27
AU2006223226A1 (en) 2006-09-21
CY1114504T1 (el) 2016-10-05
US8975242B2 (en) 2015-03-10
DK1858488T3 (da) 2013-11-04
WO2006099258A8 (en) 2007-10-04
KR20130122988A (ko) 2013-11-11
GT200600112A (es) 2006-11-29
PL1858488T3 (pl) 2014-01-31
AR109500A2 (es) 2018-12-19
ES2434944T3 (es) 2013-12-18
EP1858488B2 (en) 2022-07-20

Similar Documents

Publication Publication Date Title
AR053827A1 (es) Composiciones de tigeciclina y metodos de preparacion
AR052238A1 (es) Formulacion de tabletas estables
ECSP078055A (es) Formas sólidas cristalinas de tigeciclina y métodos para preparar las mismas
CR11548A (es) Azolilmetiloxiranos, su uso y agentes que los contienen
SV2011003888A (es) Compuestos que expanden las celulas madre hematopoieticas
ECSP099296A (es) Inmuno-reguladores, preparaciones y composiciones que incluyen los inmuno-reguladores, pruebas para evaluar la actividad de los inmuno-reguladores y preparaciones y composiciones que incluyen los mismos y métodos
AR053066A1 (es) Arabinofuranosidasas
BRPI0506839A (pt) composições e métodos para induzir a cardiomiogênese
BRPI1009981A2 (pt) sistemas , métodos e composições para otimizar os enxertos enriquecidos de tecido e célula
UY29325A1 (es) Nuevos derivados de 2 - amino-piridina
UY33124A (es) Agentes y epítopos enlazados a wise
GT201000047A (es) Mejoras en compuestos organicos o relacionadas con los mismos
BRPI0915439B8 (pt) composição de gel tópica, bem como uso de um agente ativo para tratamento de ceratose actínica em combinação com um agente ceratoliticamente ativo para preparação da referida composição
GT200600369A (es) Proceso
ECSP088140A (es) Nuevos análogos de piridina
BRPI0612424A2 (pt) composiÇÕes e mÉtodos para tratar condiÇÕes relacionadas com a sinalizaÇço da efrina com cupredoxinas
BR112012013119A2 (pt) derivados de 1-amino-piperidina-pirrolidina-diona espirocondensada com atividade pesticida.
CR9853A (es) Compuestos de exemestano (s)-6-metiloxaalquilo y metodos relacionados con su utilizacion
GT201000175A (es) Uso de derivados de ácido tetrámico para controlar nematodos
BR112015026077A8 (pt) barra de sabão, método de redução de bactérias gram positivas e uso de uma barra de sabão
CL2008001570A1 (es) Metodo organogenico para transformar celulas o tejidos de soya.
CR8537A (es) Moduladores de HM74 de Oxidecahidronaftaleno
CL2008001014A1 (es) Procedimiento para preparar comprimidos de dihidrocloruro de prampipexol.
GT200600048A (es) Pirroles sustituidos, composiciones que los contienen, proceso de fabricación y utilización.
BRPI0805245A2 (pt) poliuretanos termoplásticos auto-extinguìveis, processo para sua preparação e seu uso

Legal Events

Date Code Title Description
FC Refusal